Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Advances in the treatment of peritoneal metastases in gastric cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.08.19
Views: 918
Rating:

Dr Geraldo Alves - Hospital Santa Rosa, Brasil

Dr Geraldo Alves speaks to ecancer at the 2019 ecancer-Oncosalud Symposium of Molecular Clinical Oncology in Peru about the main advances in the treatment of peritoneal metastases in gastric cancer.

He reports the results from one study in which patients treated with a combination of hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery survived longer, compared to patients treated with cytoreductive surgery alone.

Dr Alves also describes further trials, including the
PERISCOPE II and GASTRIPEC studies, that are investigating the effect of perioperative chemotherapy plus HIPEC in high-risk patients.

 

Related videos

follow us

Tobacco Dependence e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation